Europe Kidney Cancer Drug Market Report 2016

Publisher Name :
Date: 20-Sep-2016
No. of pages: 123
Inquire Before Buying

Notes:

Sales, means the sales volume of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug

This report studies sales (consumption) of Kidney Cancer Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Bayer

- F. Hoffmann-La Roche

- GlaxoSmithKline

- Novartis

- Pfizer

- Abbott Laboratories

- Active Biotech

- Amgen

- Argos Therapeutics

- ArQule

- AVEO Pharmaceuticals

- Bionomics

- Bristol-Myers Squibb

- Cerulean Pharma

- Exelixis

- Genentech

- immatics biotechnologies

- Immunicum

- Ono Pharmaceutical

- Onyx Therapeutics

- Oxford BioMedica

- Prometheus Laboratories

- Seattle Genetics

- Taiwan Liposome

- TRACON Pharmaceuticals

- Wilex

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Kidney Cancer Drug in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by Application, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Kidney Cancer Drug Market Report 2016

Table of Contents
Europe Kidney Cancer Drug Market Report 2016
1 Kidney Cancer Drug Overview
1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Kidney Cancer Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Kidney Cancer Drug Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Kidney Cancer Drug (2011-2021)
1.5.1 Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)
1.5.2 Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
2 Europe Kidney Cancer Drug by Manufacturers, Type and Application
2.1 Europe Kidney Cancer Drug Market Competition by Manufacturers
2.1.1 Europe Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Kidney Cancer Drug (Volume and Value) by Type
2.2.1 Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
2.2.2 Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Kidney Cancer Drug (Volume and Value) by Countries
2.3.1 Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Kidney Cancer Drug (Volume) by Application
3 Germany Kidney Cancer Drug (Volume, Value and Sales Price)
3.1 Germany Kidney Cancer Drug Sales and Value (2011-2016)
3.1.1 Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)
3.1.2 Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
3.1.3 Germany Kidney Cancer Drug Sales Price Trend (2011-2016)
3.2 Germany Kidney Cancer Drug Sales and Market Share by Manufacturers
3.3 Germany Kidney Cancer Drug Sales and Market Share by Type
3.4 Germany Kidney Cancer Drug Sales and Market Share by Application
4 France Kidney Cancer Drug (Volume, Value and Sales Price)
4.1 France Kidney Cancer Drug Sales and Value (2011-2016)
4.1.1 France Kidney Cancer Drug Sales and Growth Rate (2011-2016)
4.1.2 France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
4.1.4 France Kidney Cancer Drug Sales Price Trend (2011-2016)
4.2 France Kidney Cancer Drug Sales and Market Share by Manufacturers
4.3 France Kidney Cancer Drug Sales and Market Share by Type
4.4 France Kidney Cancer Drug Sales and Market Share by Application
5 UK Kidney Cancer Drug (Volume, Value and Sales Price)
5.1 UK Kidney Cancer Drug Sales and Value (2011-2016)
5.1.1 UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)
5.1.2 UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
5.1.5 UK Kidney Cancer Drug Sales Price Trend (2011-2016)
5.2 UK Kidney Cancer Drug Sales and Market Share by Manufacturers
5.3 UK Kidney Cancer Drug Sales and Market Share by Type
5.4 UK Kidney Cancer Drug Sales and Market Share by Application
6 Russia Kidney Cancer Drug (Volume, Value and Sales Price)
6.1 Russia Kidney Cancer Drug Sales and Value (2011-2016)
6.1.1 Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
6.1.2 Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
6.1.6 Russia Kidney Cancer Drug Sales Price Trend (2011-2016)
6.2 Russia Kidney Cancer Drug Sales and Market Share by Manufacturers
6.3 Russia Kidney Cancer Drug Sales and Market Share by Type
6.4 Russia Kidney Cancer Drug Sales and Market Share by Application
7 Italy Kidney Cancer Drug (Volume, Value and Sales Price)
7.1 Italy Kidney Cancer Drug Sales and Value (2011-2016)
7.1.1 Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)
7.1.2 Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
7.1.7 Italy Kidney Cancer Drug Sales Price Trend (2011-2016)
7.2 Italy Kidney Cancer Drug Sales and Market Share by Manufacturers
7.3 Italy Kidney Cancer Drug Sales and Market Share by Type
7.4 Italy Kidney Cancer Drug Sales and Market Share by Application
8 Spain Kidney Cancer Drug (Volume, Value and Sales Price)
8.1 Spain Kidney Cancer Drug Sales and Value (2011-2016)
8.1.1 Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)
8.1.2 Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
8.1.8 Spain Kidney Cancer Drug Sales Price Trend (2011-2016)
8.2 Spain Kidney Cancer Drug Sales and Market Share by Manufacturers
8.3 Spain Kidney Cancer Drug Sales and Market Share by Type
8.4 Spain Kidney Cancer Drug Sales and Market Share by Application
9 Benelux Kidney Cancer Drug (Volume, Value and Sales Price)
9.1 Benelux Kidney Cancer Drug Sales and Value (2011-2016)
9.1.1 Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)
9.1.2 Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)
9.2 Benelux Kidney Cancer Drug Sales and Market Share by Manufacturers
9.3 Benelux Kidney Cancer Drug Sales and Market Share by Type
9.4 Benelux Kidney Cancer Drug Sales and Market Share by Application
10 Europe Kidney Cancer Drug Manufacturers Analysis
10.1 Bayer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Kidney Cancer Drug Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 F. Hoffmann-La Roche
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Kidney Cancer Drug Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 GlaxoSmithKline
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Kidney Cancer Drug Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Novartis
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Kidney Cancer Drug Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Pfizer
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Kidney Cancer Drug Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Abbott Laboratories
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Kidney Cancer Drug Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Active Biotech
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Kidney Cancer Drug Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Amgen
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Kidney Cancer Drug Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Argos Therapeutics
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Kidney Cancer Drug Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 ArQule
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Kidney Cancer Drug Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 AVEO Pharmaceuticals
10.12 Bionomics
10.13 Bristol-Myers Squibb
10.14 Cerulean Pharma
10.15 Exelixis
10.16 Genentech
10.17 immatics biotechnologies
10.18 Immunicum
10.19 Ono Pharmaceutical
10.20 Onyx Therapeutics
10.21 Oxford BioMedica
10.22 Prometheus Laboratories
10.23 Seattle Genetics
10.24 Taiwan Liposome
10.25 TRACON Pharmaceuticals
10.26 Wilex
11 Kidney Cancer Drug Manufacturing Cost Analysis
11.1 Kidney Cancer Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Kidney Cancer Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Kidney Cancer Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Kidney Cancer Drug Market Forecast (2016-2021)
14.1 Germany Kidney Cancer Drug Sales Forecast (2016-2021)
14.2 France Kidney Cancer Drug Sales Forecast (2016-2021)
14.3 UK Kidney Cancer Drug Sales Forecast (2016-2021)
14.4 Russia Kidney Cancer Drug Sales Forecast (2016-2021)
14.5 Italy Kidney Cancer Drug Sales Forecast (2016-2021)
14.6 Spain Kidney Cancer Drug Sales Forecast (2016-2021)
14.7 Benelux Kidney Cancer Drug Sales Forecast (2016-2021)
14.8 Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)
14.9 Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Kidney Cancer Drug
Figure Europe Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Sales and Growth Rate (2011-2021)
Figure Europe Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Table Europe Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table Europe Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 Europe Kidney Cancer Drug Revenue Share by Manufacturers
Table Europe Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Europe Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)
Table Europe Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
Table Europe Kidney Cancer Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2011-2016)
Figure Europe Kidney Cancer Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Kidney Cancer Drug Sales and Market Share by Countries (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Countries (2011-2016)
Table Europe Kidney Cancer Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Kidney Cancer Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Countries (2011-2016)
Table Europe Kidney Cancer Drug Sales and Market Share by Application (2011-2016)
Table Europe Kidney Cancer Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Kidney Cancer Drug by Application (2011-2016)
Figure Germany Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Germany Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Germany Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Germany Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Germany Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure France Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure France Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure France Kidney Cancer Drug Sales Price Trend (2011-2016)
Table France Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table France Kidney Cancer Drug Sales by Type (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table France Kidney Cancer Drug Sales by Application (2015 and 2016)
Table France Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure UK Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure UK Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure UK Kidney Cancer Drug Sales Price Trend (2011-2016)
Table UK Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Type (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table UK Kidney Cancer Drug Sales by Application (2015 and 2016)
Table UK Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Russia Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Russia Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Russia Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Russia Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Russia Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Italy Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Italy Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Italy Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Italy Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Italy Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Spain Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Spain Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Spain Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Spain Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Spain Kidney Cancer Drug Market Share by Application (2015 and 2016)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate (2011-2016)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Kidney Cancer Drug Sales Price Trend (2011-2016)
Table Benelux Kidney Cancer Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Type (2015 and 2016)
Table Benelux Kidney Cancer Drug Sales by Application (2015 and 2016)
Table Benelux Kidney Cancer Drug Market Share by Application (2015 and 2016)
Table Kidney Cancer Drug Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Kidney Cancer Drug Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Kidney Cancer Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Kidney Cancer Drug Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Active Biotech Kidney Cancer Drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Kidney Cancer Drug Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table ArQule Basic Information List
Table ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ArQule Kidney Cancer Drug Sales Market Share (2011-2016)
Table AVEO Pharmaceuticals Basic Information List
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Kidney Cancer Drug Sales Market Share (2011-2016)
Table Cerulean Pharma Basic Information List
Table Cerulean Pharma Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cerulean Pharma Kidney Cancer Drug Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Kidney Cancer Drug Sales Market Share (2011-2016)
Table immatics biotechnologies Basic Information List
Table immatics biotechnologies Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table immatics biotechnologies Kidney Cancer Drug Sales Market Share (2011-2016)
Table Immunicum Basic Information List
Table Immunicum Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunicum Kidney Cancer Drug Sales Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information List
Table Ono Pharmaceutical Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ono Pharmaceutical Kidney Cancer Drug Sales Market Share (2011-2016)
Table Onyx Therapeutics Basic Information List
Table Onyx Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Oxford BioMedica Basic Information List
Table Oxford BioMedica Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford BioMedica Kidney Cancer Drug Sales Market Share (2011-2016)
Table Prometheus Laboratories Basic Information List
Table Prometheus Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prometheus Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Taiwan Liposome Basic Information List
Table Taiwan Liposome Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiwan Liposome Kidney Cancer Drug Sales Market Share (2011-2016)
Table TRACON Pharmaceuticals Basic Information List
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Wilex Basic Information List
Table Wilex Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wilex Kidney Cancer Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure Germany Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Kidney Cancer Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Type (2016-2021)
Table Europe Kidney Cancer Drug Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 3480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • North America Vegetable (HPMC) Capsule Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-May-2017        Price: US 4480 Onwards        Pages: 116
    Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. These ca......
  • Global Compounding Pharmacy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 116
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • Global Sufentanil (API) Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Sufentanil (API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sufentanil (API) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Communicable Diseases Treatment Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Communicable Diseases Treatment market, analyzes and researches the Communicable Diseases Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Bristol-Myers Squibb Pharmaceutical - Eli Lilly - GlaxoSmithKline - Johnson & Johnson - Medtronic - Merck - Pfizer - F. Hoffmann-La Roche - Sanofi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs